This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

James Ernst, Ph.D.
Vice President, Head of Protein Sciences and Technology Department at Xencor
Speaker

Profile


James Ernst is Vice President of Development Sciences and Head of the Protein Sciences and Technology Department at Xencor, Inc. where he leads efforts to translate molecules from discovery research into clinical development. Prior to joining Xencor, James held various leadership positions in the Genentech Research and Early Development (gRED) Protein Sciences organization. He has more than 20 years of experience supporting all stages of therapeutic development from target identification to clinical validation. He has worked with and led both large and small molecule therapy discovery teams in a variety of therapeutic areas including autoimmune, oncology, neuroscience, and metabolic disease He received his Ph.D. from Yale University and completed postdoctoral training at Stanford University Medical School.

Agenda Sessions

  • Mid-Career Scientist Career Perspectives, Lessons Learned

    11:10am
  • Panel Discussion and Extended Q&A

    11:30am
  • Co-Chairs’ Remarks - Novel Bispecific and Multi-specific Antibodies

    8:10am